Clinical Trial

Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCT

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 24, 2024 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study was a prospective, multicenter, single-arm clinical study planned to enroll 60 patients who developed hemorrhagic cystitis after sexually allogeneic hematopoietic stem cell transplantation Patients with hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation were given symptomatic supportive treatment combined with moxibustion covering Shenque, Zhongguo, Guanyuan, and Qihai for 30 minutes every day for 14 days and urine routine was collected every day for 14 days to assess the severity of hemorrhagic cystitis and pain scores to evaluate the effectiveness of moxibustion in treating hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06241274
Lead Sponsor Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions Moxibustion, Hematopoietic Stem Cell Transplantation, Hemorrhagic Cystitis, Treatment
Enrollment 60 participants
Start Date 2024-08-15
Primary Completion 2025-09-30 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-07-24